Texas bills · 89th Legislature (2025)
Texas HB 3717
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
Cosponsors (29)
- Alders (Republican)
- Barry (Republican)
- Bell, Keith (Republican)
- Buckley (Republican)
- Cain (Republican)
- Davis, Aicha (Democratic)
- Gámez (Democratic)
- Garcia, Josey (Democratic)
- Gerdes (Republican)
- Hefner (Republican)
- LaHood (Republican)
- Lalani (Democratic)
- Leo Wilson (Republican)
- Lopez, Janie (Republican)
- Lujan (Republican)
- McLaughlin (Republican)
- Metcalf (Republican)
- Morales Shaw (Democratic)
- Morales, Eddie (Democratic)
- Olcott (Republican)
- Pierson (Republican)
- Raymond (Democratic)
- Schoolcraft (Republican)
- Shofner (Republican)
- Swanson (Republican)
- Tinderholt (Republican)
- Vasut (Republican)
- Villalobos (Republican)
- Zwiener (Democratic)
Summary
No official summary is available for this bill.
Latest action(May 12, 2025): Laid on the table subject to call
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- May 12, 2025 · House
Laid on the table subject to call - May 12, 2025 · House
Companion considered in lieu of - May 12, 2025 · House
Postponed - May 12, 2025 · House
Laid out as postponed business - May 9, 2025 · House
Postponed - May 9, 2025 · House
Laid out as postponed business - May 7, 2025 · House
Postponed - May 7, 2025 · House
Laid out as postponed business - May 5, 2025 · House
Postponed - May 5, 2025 · House
Read 2nd time - May 2, 2025 · House
Placed on General State Calendar - Apr 30, 2025 · House
Considered in Calendars - Apr 25, 2025 · House
Committee report sent to Calendars - Apr 23, 2025 · House
Committee report distributed - Apr 23, 2025 · House
Comte report filed with Committee Coordinator - Apr 14, 2025 · House
Reported favorably w/o amendment(s) - Apr 14, 2025 · House
Considered in public hearing - Apr 7, 2025 · House
Left pending in committee - Apr 7, 2025 · House
Testimony taken/registration(s) recorded in committee - Apr 7, 2025 · House
Considered in public hearing - Mar 26, 2025 · House
Referred to Public Health - Mar 26, 2025 · House
Read first time - Mar 4, 2025 · House
Filed